Mannose is a type of sugar, similar to glucose. It's found in some fruits and plants. It's important for how your body processes certain carbohydrates and is used in some medical research.
Every report comes from a Lived member, sent anonymously.
Have you tried Mannose for UTI (Urinary Tract Infection)?
Mannose, usually sold as D-mannose, is a simple sugar related to glucose. Small amounts are part of normal human metabolism and ordinary food. In the US it is sold over the counter as a supplement in powders, capsules and tablets, often marketed to prevent bladder infections, and it is not an FDA-approved drug for that use. Most people who take it are trying to prevent recurrent urinary tract infections (UTIs), meaning infections that keep coming back, typically two or more in six months or three or more in a year. The evidence for this is weak. A large UK trial in women treated in primary care compared daily D-mannose with a placebo powder for six months and found no meaningful difference in repeat infections. Earlier, smaller studies that reported fewer infections did not use a placebo. A European urology guideline still allows it as an option but says people should be told the evidence is weak and contradictory. D-mannose has a very different, well-established role in a rare inherited disease called MPI-CDG (mannose phosphate isomerase deficiency). In this condition, usually found in infancy, the body cannot properly attach sugar chains to proteins, which can cause severe diarrhea, low blood sugar, liver disease and clotting problems. Oral D-mannose is the main treatment and is taken for life under a metabolic specialist.
Most bladder infections are caused by E. coli bacteria that grip the lining of the bladder using tiny hair-like structures. Those structures latch onto mannose-containing molecules on bladder cells. The idea behind the supplement is that D-mannose passing into the urine acts as a decoy: bacteria bind to the free sugar instead of the bladder wall and are flushed out when you urinate. This anti-sticking effect is well shown in the laboratory, but it has not translated into a clear reduction in infections in people. In MPI-CDG, the missing enzyme normally supplies the mannose the body needs to build sugar chains on proteins, including clotting proteins and proteins made by the liver. Taking extra mannose by mouth gives the body another route to that building block, which is why specialists track clotting tests and a blood test of protein glycosylation to judge whether the dose is working.
As a supplement, D-mannose is usually a white, sweet-tasting powder dissolved in water, or capsules. The trials that studied recurrent UTIs mostly used about 2 grams a day, and study doses have ranged from 200 milligrams to 2 to 3 grams. Product strengths and added ingredients such as cranberry vary, and supplements are not checked by the FDA for dose accuracy the way prescription drugs are. For MPI-CDG, the dose is set and adjusted by the metabolic team based on symptoms and blood tests, and should not be stopped or reduced without their advice.
D-mannose is generally well tolerated. In trials, side effects were few and none were serious. The most common were loose stools or diarrhea, and some women reported vaginal burning.
D-mannose does not treat an active infection. If you have burning when you urinate, need to go often or notice cloudy or bloody urine, see a clinician, because a confirmed UTI is treated with antibiotics and delay can let it spread. Fever, shakiness or pain in the back or side below the ribs can mean the infection has reached the kidneys and needs same-day medical care. Safety in pregnancy and breastfeeding has not been established. Pregnant women were excluded from the UTI trials, and animal studies raised concerns about effects on a developing baby, so talk with a clinician before using it if you are pregnant or planning to be. People with MPI-CDG who become pregnant need specialist planning rather than simply stopping treatment. Because it is a sugar, people with diabetes may want to ask how it fits their blood sugar plan, and anyone taking other medicines or supplements should mention it to their pharmacist.
If you try D-mannose to prevent UTIs, judge it over several months by whether infections actually become less frequent, and keep track of episodes and antibiotic courses. Many people in the large trial continued to have infections at about the same rate as with placebo, so it is reasonable to stop if nothing changes. Other options for recurrent UTIs, such as vaginal estrogen after menopause or, when other measures fail, low-dose preventive antibiotics, have stronger evidence and are worth discussing. For people with MPI-CDG, treatment is lifelong. Long-term follow-up shows that people who take it consistently usually do well, while missed doses are linked with the return of diarrhea, abnormal blood tests and blood clots. Treatment does not always reverse existing liver scarring, so regular liver and clotting checks remain part of care.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Mannose, what you've noticed, or ask the community a question.